These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 34433082)
1. Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose. Rhoades NS; Pinski AN; Monsibais AN; Jankeel A; Doratt BM; Cinco IR; Ibraim I; Messaoudi I Cell Rep; 2021 Aug; 36(9):109637. PubMed ID: 34433082 [TBL] [Abstract][Full Text] [Related]
2. Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including Rhoades NS; Pinski A; Monsibais AN; Jankeel A; Doratt BM; Cinco IR; Ibraim I; Messaoudi I bioRxiv; 2021 May; ():. PubMed ID: 34031657 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome. Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896 [TBL] [Abstract][Full Text] [Related]
4. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349 [TBL] [Abstract][Full Text] [Related]
8. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600 [TBL] [Abstract][Full Text] [Related]
9. The characteristics of microbiome in the upper respiratory tract of COVID-19 patients. Zhang X; Nurxat N; Aili J; Yasen Y; Wang Q; Liu Q BMC Microbiol; 2024 Apr; 24(1):138. PubMed ID: 38658823 [TBL] [Abstract][Full Text] [Related]
10. Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Qu J; Cai Z; Liu Y; Duan X; Han S; Liu J; Zhu Y; Jiang Z; Zhang Y; Zhuo C; Liu Y; Liu Y; Liu L; Yang L Front Cell Infect Microbiol; 2021; 11():641920. PubMed ID: 33816347 [No Abstract] [Full Text] [Related]
11. Associated factors of respiratory co-infection of COVID-19 and the impact of co-infection on SARS-CoV-2 viral load. Hu X; Zhang F; Jia J; Xin X; Dai X; Dong L; Wang Z; Jiang F J Infect Dev Ctries; 2024 Aug; 18(8):1204-1211. PubMed ID: 39288393 [TBL] [Abstract][Full Text] [Related]
12. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19. Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448 [TBL] [Abstract][Full Text] [Related]
13. Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients. He F; Xia X; Nie D; Yang H; Jiang Y; Huo X; Guo F; Fang B; Hu B; Jiang H; Zhan F; Lv J Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115199. PubMed ID: 32979617 [TBL] [Abstract][Full Text] [Related]
14. High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity. Akorli J; Opoku M; Appiah-Twum F; Akpo MS; Ismail RY; Boamah GYK; Obeng-Aboagye E; Adu-Asamoah D; Donkor IO BMC Infect Dis; 2024 Sep; 24(1):1020. PubMed ID: 39304808 [TBL] [Abstract][Full Text] [Related]
15. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Sulaiman I; Chung M; Angel L; Tsay JJ; Wu BG; Yeung ST; Krolikowski K; Li Y; Duerr R; Schluger R; Thannickal SA; Koide A; Rafeq S; Barnett C; Postelnicu R; Wang C; Banakis S; Pérez-Pérez L; Shen G; Jour G; Meyn P; Carpenito J; Liu X; Ji K; Collazo D; Labarbiera A; Amoroso N; Brosnahan S; Mukherjee V; Kaufman D; Bakker J; Lubinsky A; Pradhan D; Sterman DH; Weiden M; Heguy A; Evans L; Uyeki TM; Clemente JC; de Wit E; Schmidt AM; Shopsin B; Desvignes L; Wang C; Li H; Zhang B; Forst CV; Koide S; Stapleford KA; Khanna KM; Ghedin E; Segal LN Nat Microbiol; 2021 Oct; 6(10):1245-1258. PubMed ID: 34465900 [TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types. Gupta A; Karyakarte R; Joshi S; Das R; Jani K; Shouche Y; Sharma A Microbes Infect; 2022 Feb; 24(1):104880. PubMed ID: 34425246 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
18. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients. Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and Clinical Impact of Coinfection in Patients with Coronavirus Disease 2019 in Korea. Jeong S; Lee N; Park Y; Kim J; Jeon K; Park MJ; Song W Viruses; 2022 Feb; 14(2):. PubMed ID: 35216039 [TBL] [Abstract][Full Text] [Related]
20. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]